Innospec Inc. (NASDAQ:IOSP - Free Report) - Equities research analysts at Seaport Res Ptn lowered their Q2 2025 earnings estimates for shares of Innospec in a report issued on Friday, July 18th. Seaport Res Ptn analyst M. Harrison now anticipates that the specialty chemicals company will post earnings per share of $1.17 for the quarter, down from their prior estimate of $1.23. Seaport Res Ptn currently has a "Strong-Buy" rating on the stock. The consensus estimate for Innospec's current full-year earnings is $6.18 per share. Seaport Res Ptn also issued estimates for Innospec's Q3 2025 earnings at $1.28 EPS, FY2025 earnings at $5.47 EPS and FY2026 earnings at $6.50 EPS.
Innospec (NASDAQ:IOSP - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The specialty chemicals company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.40 by $0.02. The business had revenue of $440.80 million during the quarter, compared to the consensus estimate of $466.50 million. Innospec had a net margin of 1.51% and a return on equity of 11.38%. The company's quarterly revenue was down 11.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.75 earnings per share.
Separately, Wall Street Zen downgraded shares of Innospec from a "buy" rating to a "hold" rating in a research note on Tuesday, May 6th.
Check Out Our Latest Stock Report on IOSP
Innospec Stock Down 2.3%
NASDAQ:IOSP opened at $83.02 on Monday. The company has a fifty day simple moving average of $86.35 and a two-hundred day simple moving average of $95.42. The company has a market cap of $2.07 billion, a price-to-earnings ratio of 76.87 and a beta of 1.05. Innospec has a 52 week low of $80.32 and a 52 week high of $133.53.
Institutional Investors Weigh In On Innospec
Institutional investors have recently modified their holdings of the company. Tsfg LLC purchased a new stake in Innospec in the first quarter valued at $35,000. Murphy & Mullick Capital Management Corp purchased a new stake in Innospec in the fourth quarter valued at $106,000. Covestor Ltd lifted its position in Innospec by 13.9% in the fourth quarter. Covestor Ltd now owns 967 shares of the specialty chemicals company's stock valued at $106,000 after acquiring an additional 118 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in Innospec in the first quarter valued at $121,000. Finally, Polymer Capital Management US LLC purchased a new stake in Innospec in the fourth quarter valued at $201,000. 96.64% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other news, Director Leslie J. Parrette sold 446 shares of Innospec stock in a transaction on Tuesday, May 13th. The shares were sold at an average price of $90.63, for a total transaction of $40,420.98. Following the completion of the sale, the director directly owned 5,497 shares of the company's stock, valued at approximately $498,193.11. The trade was a 7.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.31% of the company's stock.
Innospec Increases Dividend
The company also recently disclosed a semi-annual dividend, which was paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th were given a dividend of $0.84 per share. This is a boost from Innospec's previous semi-annual dividend of $0.79. This represents a dividend yield of 1.7%. The ex-dividend date was Tuesday, May 20th. Innospec's payout ratio is 155.56%.
About Innospec
(
Get Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.